SCHEMBL18426709

SCHEMBL18426709

C[C@H]([AsH2])c1ccc(CO)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 1/20 0.41
▸ PRSS2 P07478 1/20 0.41
▸ PRSS3 P35030 1/20 0.41
▸ TSHR P16473 3/20 0.40
▸ ESR1 P03372 2/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ ADRB3 P13945 2/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ ADRB1 P08588 1/20 0.37
▸ VHL P40337 1/20 0.35
▸ ELOC Q15369 1/20 0.35
▸ ELOB Q15370 1/20 0.35
▸ LTA4H P09960 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18426712 1.00 PRSS1 (0.41) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL113930 0.80 IDO1 (0.52) TSHRESR1ESR2NOS3NOS1
SCHEMBL7544326 0.80 ESR1 (0.52) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL40702 0.78 NOS3 (0.42) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL18118664 0.78 NOS3 (0.42) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL23040222 0.76 TSHR (0.40) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL1936039 0.76 ADRB2 (0.50) PRSS1PRSS2PRSS3TSHRESR1
SCHEMBL18426926 0.76 ADRB2 (0.50) PRSS1PRSS2PRSS3TSHRESR1
Alcohol SCHEMBL5309262 0.76 IDO1 (0.48) TSHRESR1ESR2NOS3NOS1
SCHEMBL1754169 0.76 ADRB2 (0.50) PRSS1PRSS2PRSS3TSHRESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328866-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS Eli Lilly and Company (US) 2018-06-06 — — EP disclosed
WO-2017019429-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS ELI LILLY AND COMPANY (US) 2017-02-02 — — WO disclosed
Send feedback